Duloxetine
Product Images NDC 50090-2844

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-2844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)
FDA Label Image

Fig2 (Duloxetine Fig2)

Fig2 (Duloxetine Fig2)
FDA Label Image

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)
FDA Label Image

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)
FDA Label Image

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)
The text represents a graph showing the percentage of patients who reported improvement in pain after using a medication. The x-axis shows the percentage of improvement in pain from baseline, while the y-axis shows the percentage of patients who reported improvement. The graph includes three lines, representing Duloxetine 60 mg twice daily, Duloxetine 60 mg once daily, and a placebo. The data shows that the percentage of patients who reported improvement increased as the percentage of improvement in pain increased.*
FDA Label Image

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)
This appears to be a graph or chart showing the percentage of patients who experienced improvement in pain levels after taking Duloxetine at different dosages. The dosages listed are 120mg, 60mg, and 20mg taken once daily. The graph also includes a placebo line for comparison.*
FDA Label Image

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)
The text shows a chart that compares the percentage of patients who improved their pain levels after taking either a placebo or a medication called Duloxetine 60/120 mg once. The chart indicates that all patients who took Duloxetine saw an improvement in their condition, while the placebo group didn't show any improvement. Additionally, the chart includes a table with values ranging from 0 to 100, which seems to indicate the percent improvement in pain from baseline, using the BOCF method.*
FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
The text appears to be a graph displaying the percentage of pain improvement from baseline (BOCF) for patients taking Placeto and Dulowetine at 60/120 mg once daily. There are no additional details or context provided.*
FDA Label Image

Structure (Duloxetine Str)

Structure (Duloxetine Str)
FDA Label Image

Label Image (Lbl500902844)

Label Image (Lbl500902844)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.